228 related articles for article (PubMed ID: 15364150)
41. Willingness to pay to assess patient preferences for therapy in a Canadian setting.
Marra CA; Frighetto L; Goodfellow AF; Wai AO; Chase ML; Nicol RE; Leong CA; Tomlinson S; Ferreira BM; Jewesson PJ
BMC Health Serv Res; 2005 Jun; 5():43. PubMed ID: 15941474
[TBL] [Abstract][Full Text] [Related]
42. Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial.
Moses JW; Mehran R; Nikolsky E; Lasala JM; Corey W; Albin G; Hirsch C; Leon MB; Russell ME; Ellis SG; Stone GW
J Am Coll Cardiol; 2005 Apr; 45(8):1165-71. PubMed ID: 15837244
[TBL] [Abstract][Full Text] [Related]
43. Comparison of long-term (seven year) outcomes among patients undergoing percutaneous coronary revascularization with versus without stenting.
Kandzari DE; Tuttle RH; Zidar JP; Jollis JG
Am J Cardiol; 2006 May; 97(10):1467-72. PubMed ID: 16679085
[TBL] [Abstract][Full Text] [Related]
44. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization.
McCollam P; Etemad L
J Invasive Cardiol; 2005 Jun; 17(6):307-11. PubMed ID: 16003005
[TBL] [Abstract][Full Text] [Related]
45. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
[TBL] [Abstract][Full Text] [Related]
46. Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation.
Chu WW; Torguson R; Pichard AD; Satler LF; Chan R; Porrazzo M; Kent KM; Suddath WO; Waksman R
J Invasive Cardiol; 2005 Dec; 17(12):659-62. PubMed ID: 16327049
[TBL] [Abstract][Full Text] [Related]
47. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
Tamburino C; Angiolillo DJ; Capranzano P; Dimopoulos K; La Manna A; Barbagallo R; Tagliareni F; Mangiafico S; Guzman LA; Galassi AR; Bass TA
Catheter Cardiovasc Interv; 2008 Oct; 72(4):448-56. PubMed ID: 18814218
[TBL] [Abstract][Full Text] [Related]
48. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J
J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823
[TBL] [Abstract][Full Text] [Related]
49. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
[TBL] [Abstract][Full Text] [Related]
50. [Drug-eluting stents in patients with left main coronary lesions who are not candidates for surgical revascularization].
Lozano I; Herrera C; Morís C; Gómez-Hospital JA; Rondán J; Iráculis E; Martín M; Cequier A; Suárez E; Esplugas E
Rev Esp Cardiol; 2005 Feb; 58(2):145-52. PubMed ID: 15743560
[TBL] [Abstract][Full Text] [Related]
51. Perception of the economic value of primary care services: a Willingness to Pay study.
Martín-Fernández J; Gómez-Gascón T; Oliva-Moreno J; del Cura-González MI; Domínguez-Bidagor J; Beamud-Lagos M; Sanz-Cuesta T
Health Policy; 2010 Mar; 94(3):266-72. PubMed ID: 19945763
[TBL] [Abstract][Full Text] [Related]
52. A utility-theoretic approach to the aggregation of willingness to pay measured in decomposed scenarios: development and empirical test.
Hammerschmidt T; Zeitler HP; Leidl R
Health Econ; 2004 Apr; 13(4):345-61. PubMed ID: 15067672
[TBL] [Abstract][Full Text] [Related]
53. The impact of information on patient preferences in different delivery patterns: a contingent valuation study of prescription versus OTC drugs.
Lamiraud K; von Bremen K; Donaldson C
Health Policy; 2009 Dec; 93(2-3):102-10. PubMed ID: 19604597
[TBL] [Abstract][Full Text] [Related]
54. Use of willingness to pay to study values for pharmacotherapies for migraine headache.
Lenert LA
Med Care; 2003 Feb; 41(2):299-308. PubMed ID: 12555057
[TBL] [Abstract][Full Text] [Related]
55. Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone.
Pinto-Prades JL; Farreras V; de Bobadilla JF
Eur J Health Econ; 2008 Feb; 9(1):69-78. PubMed ID: 17447095
[TBL] [Abstract][Full Text] [Related]
56. Stated and actual altruistic willingness to pay for insecticide-treated nets in Nigeria: validity of open-ended and binary with follow-up questions.
Onwujekwe O; Uzochukwu B
Health Econ; 2004 May; 13(5):477-92. PubMed ID: 15127427
[TBL] [Abstract][Full Text] [Related]
57. Willingness to pay for a QALY.
Gyrd-Hansen D
Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
[TBL] [Abstract][Full Text] [Related]
58. The value of informal care--a further investigation of the feasibility of contingent valuation in informal caregivers.
de Meijer C; Brouwer W; Koopmanschap M; van den Berg B; van Exel J
Health Econ; 2010 Jul; 19(7):755-71. PubMed ID: 19548326
[TBL] [Abstract][Full Text] [Related]
59. Willingness to pay for public health services in rural Central Java, Indonesia: methodological considerations when using the contingent valuation method.
Shono A; Kondo M; Ohmae H; Okubo I
Soc Sci Med; 2014 Jun; 110():31-40. PubMed ID: 24713191
[TBL] [Abstract][Full Text] [Related]
60. A cost-benefit analysis using contingent valuation techniques: a feasibility study in spinal surgery.
Haefeli M; Elfering A; McIntosh E; Gray A; Sukthankar A; Boos N
Value Health; 2008; 11(4):575-88. PubMed ID: 18179657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
